/
Sign inStart free
Menu

Company File · BSE 532300 · Latest filing Q1 FY27

Standalone = this company only. Consolidated = including its subsidiaries.

Wockhardt Ltd

Data as of 19 Oct 2026 close · BSE · Latest results Q1 FY27

ISIN INE049B01025 · WOCKPHARMA · Healthcare › Pharmaceuticals & Biotechnology

About the business

What does Wockhardt do? It is a Mumbai-based pharma company focused on research into new antibiotics. Why does that matter? These drugs work against drug-resistant infections, where older antibiotics fail; its in-house examples include Miqnaf & Zaynich. Wockhardt also sells generic medicines & biosimilar insulin in India & in international markets, including the UK & Ireland.

Price & valuation · BSE close, 19 Oct 2026

Share price₹1,906.45▼ 2.2% on the day▲ 42.2% in 1 year
Market cap₹30,977 Cr16.25 crore shares× the latest BSE close
P/E87.1×Usual 110.8×
Below its usual level
PEG–EPS a year ago was a loss
Latest filingQ1 FY27
Sales growth
+35.8%
Profit growth
+55.1%
Op. margin
28.2%
P/E
87.1×
Usual P/E
110.8×
Price/book
10.0×
ROCE
10.8%
ROE
10.9%
Debt/equity
0.57×
Promoter
49.08%
Pledged
14.68%

Earnings callsNo earnings-call transcript from Wockhardt in our data yet. When it files one on BSE, the call notes appear here within a few hours. See its call page

01

Is it expensive, and is it a good business?

Key ratios

Standalone · price as of 19 Oct 2026

In short Priced below its own usual level (P/E 87.1× vs 110.8×), earns low returns on capital (ROCE 10.8%) and borrows ₹0.57 for every ₹1 of shareholders' money.

What you pay Valuation

Stock P/EBelow usual1-year median 110.8×
87.1×

Buyers pay about ₹87 for every ₹1 the company earned per share over the last year. Below its 1-year median of 110.8×.

Latest BSE close ÷ last four quarters' basic EPS. Uses earnings per share from continuing operations, so a one-off gain from selling a business does not flatter it. As of 19th October 2026.

Price to book valueAbove usual1-year median 8.1×
10.0×

The share price is 10.0 times the accounting value of each share. Above its 1-year median of 8.1×.

Latest BSE close ÷ book value per share (equity ÷ shares) on the latest balance-sheet date. As of 19th October 2026.

Price to salesMarket value ÷ yearly sales
16.4×

The market values the company at 16.4 times its yearly sales.

Market value ÷ last 12 months' revenue. As of 19th October 2026.

EV / EBITDAYears of operating profit
59.8×

The whole business (shares plus debt, minus cash) is valued at about 59.8 years of its operating profit.

Enterprise value ÷ last 12 months' EBITDA. As of 19th October 2026.

PEG ratioEPS a year ago was a loss
–

Earnings a year earlier were a loss or nil, so growth cannot be measured.

P/E ÷ 12-month EPS growth in % (the last four quarters vs the four before; when those are not all held, the latest financial year vs the year before). Growth above 100% counts as 100%; left blank when EPS fell or was below ₹1 a share a year earlier. Without one-off items when either year has large ones, as for the P/E. As of 19th October 2026.

Dividend yieldNo dividend in the last 12 months
0.00%

The company paid no dividend in the last 12 months.

Dividends per share with an ex-date in the last 12 months (restated for any split or bonus since) ÷ the latest BSE close. As of 19th October 2026.

How well it uses money Returns & strength

ROCE▲ Up from 4.4% a year earlier
10.8%

Each ₹100 of shareholders' money and debt earned about ₹10.8 before interest & tax.

Last 12 months' profit before interest & tax ÷ average (equity + borrowings). As of 31st March 2026.

ROEProfit on shareholders' money
10.9%

For every ₹100 of shareholders' money, the company earned about ₹10.9 in a year.

Last 12 months' profit after tax (continuing operations where reported) ÷ average equity. As of 31st March 2026.

ROIC
11.1%

The money actually tied up in running the business (leaving out spare cash) earned about 11.1% after tax.

Last 12 months' operating profit after tax (profit before interest & tax × (1 − effective tax rate)) ÷ average invested capital (equity + borrowings − cash & bank balances). As of 31st March 2026.

Asset turnoverSales per ₹1 of assets
0.31×

Every ₹1 of assets generated about ₹0.31 of sales in a year.

Last 12 months' revenue ÷ average total assets. As of 31st March 2026.

Interest coverageTimes profit covers interest
3.00×

Operating profit covered interest costs about 3 times.

Last 12 months' profit before interest & tax ÷ finance costs. As of 30th June 2026.

Debt to equityBorrowings ÷ equity
0.57×

For every ₹1 of shareholders' money, it has borrowed ₹0.57.

Borrowings ÷ shareholders' equity on the latest balance-sheet date. As of 31st March 2026.

Who owns it Ownership & more

Promoter holdingOwned by the promoter group
49.08%

The founders or parent group own 49.08% of the company.

Promoter & promoter group shareholding from the latest shareholding pattern filed with BSE. As of 30th June 2026.

Change in promoter holdingUnchanged from the previous quarter
0.00 pts

Promoter holding did not change over the last quarter.

Latest quarter's promoter holding minus the previous quarter's. As of 30th June 2026.

Promoter holding, quarter by quarter
  1. Jun 202649.08%
  2. Mar 202649.08%
  3. Dec 202549.08%
  4. Sep 202549.08%
Pledged percentageOf promoter shares · 7.21% of the company
14.68%

Promoters have pledged 14.68% of their shares (117.1 lakh shares), 7.21% of the company.

Promoter group shares pledged ÷ all the promoter group's shares, from the shareholding pattern filed with BSE each quarter (other encumbrances, such as non-disposal undertakings, are not counted). As of 30th June 2026.

Pledged, quarter by quarter
  1. Jun 202614.68%
  2. Mar 202618.82%
  3. Dec 202518.04%
  4. Sep 202521.30%
Free cash flow (latest year)Year to Mar 2026
₹155 Cr

After paying for new plant & equipment, operations left ₹155 crore of cash.

Cash from operations − spending on plant & equipment, latest full year. As of 31st March 2026.

Free cash flow, year by year
  1. FY26₹155 Cr
  2. FY25₹-55 Cr
Face valuePer share
₹5

Each share has a face (nominal) value of ₹5. It matters for dividends quoted as a percentage, not for valuation.

Face value per share as BSE lists it today.

No. of equity sharesCrore shares in issue
16.25 Cr

About 16.25 crore shares were in issue.

BSE's count of listed shares (BSE's market cap ÷ its price), so splits, bonuses & new shares since the latest results are included. As of 19th October 2026.

Tap the i beside any ratio for a plain explanation.

How these are worked out

Price-based ratios use the latest BSE close (19th October 2026). Share count 16.25 crore, from paid-up capital in the 19th October 2026 filing. Figures are standalone.

What you pay: Higher numbers mean you pay more for each rupee the company earns or owns.

How well it uses money: Higher returns mean each rupee in the business earns more. Lower debt means less strain.

Who owns it: A steady promoter stake with nothing pledged is a calm sign.

+ Add your own ratios

Your choices are remembered on this device.

Last 4 quarters ₹ crore · Standalone

₹ croreQ2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue from operations380.0430.0516.0561.0
EBITDA113.0113.0161.0158.0
Operating margin29.7%26.3%31.2%28.2%
One-off items–−10.0+35.0–
Profit after tax54.028.0167.0107.0
Profit after tax without one-offs54.035.5140.8107.0
Basic EPS (₹)3.261.7310.296.62

One-off items: exceptional items reported separately in the filing. Profit without one-offs takes them out after tax at 25%.

Latest filings BSE

Corporate announcements 5

Quarterly results 5

Conference calls 0

None in the filings we hold.

Investor presentations 0

None in the filings we hold.

Members see every filing, and what each means for the company in Corporate Intelligence.

The full Company File

  • Price, P/E, P/B & returns charts
  • Growth vs last year, explained
  • Cash from operations vs profit
  • Accounts checks
  • Who owns it
  • 8 quarters, balance sheet & cash flow
  • Every BSE filing, in four panels
  • Excel & CSV downloads

Subscribe or sign up free to follow 2 companies

Education & analysis only, not investment advice or a recommendation.

HV Investing Premium

Get the full story on this company

See Premium plans

₹499 a month or ₹4,999 a year. Cancel anytime.

or start free, no card needed

Already a member?Sign in